Skip to main content
. 2018 Mar 5;35(5):871–877. doi: 10.1007/s10815-018-1147-z

Table 1.

Patient demographics (N = 259) and embryo quality

Patient demographics
 Age (median, range) 35 [31–38]
 BMI (Median, range) 25 [22–28]
 Ethnicity (N, %)
  White 157 (60)
  Black 22 (8)
  Hispanic 34 (13)
  Asian 46 (17)
 #Embryonic biopsies 1510
Embryo quality mtDNA content (median, range)
 All embryos (N = 1510) (n, %) 0.000741 [0.0004375–0.00144]
  *High-quality (grade 1) 951 (62) 0.000719 [0.000421–0.0013]
  Mid—2 331 (21) 0.000736 [0.000409–0.00146]
  Poor—3 228 (15) 0.000925 [0.000532–0.00275]
 Euploid embryos 717 0.000637 [0.00037–0.00100]
  *High-quality (grade 1) 521 (72) 0.000624 [0.000363–0.00097]
  Mid—2 140 (20) 0.000623 [0.00037–0.00112]
  Poor—3 56 (8) 0.000656 [0.0003915–0.0009345]

*The Gardner blastocyst grading system assigns three separate quality scores to each blastocyst embryo: (1) Blastocyst development stage—expansion and hatching status (1 = blastocoel cavity less than ½ the volume of the embryo; 2 = blastocoel cavity more than ½ the volume of the embryo; 3 = full blastocyst/cavity completely filling the embryo; 4 = expanded blastocyst/cavity larger than the embryo with thinning of the shell; 5 = hatching out of the cell; 6 = hatched out of the shell. (2) Inner cell mass (ICM) score, or quality (A = numerous and tightly packed; B = several and loosely packed cells; C = few cells). (3) Trophectoderm (TE) score, or quality (A = many tightly packed cells organized into epithelium; B = several cells organized into loose epithelium; C = few cells) grade was defined as follows: 1—High (3 to 6 AA and 4 to 6 AB); 2—Mid (any BB, 1 to 3 AB, and 1 to 2 AA); and 3—Poor (any AC, CA, BC, CB, or CC)